000 01666 a2200421 4500
005 20250517212647.0
264 0 _c20190913
008 201909s 0 0 eng d
022 _a1538-9235
024 7 _a10.1097/OPX.0000000000001212
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLabrador-Velandia, Sonia C
245 0 0 _aFluorescein Angiography Indications: Changes after Optical Coherence Tomography and Antiangiogenics.
_h[electronic resource]
260 _bOptometry and vision science : official publication of the American Academy of Optometry
_c05 2018
300 _a435-442 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aBevacizumab
_xtherapeutic use
650 0 4 _aDiabetic Retinopathy
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aFluorescein Angiography
_xstatistics & numerical data
650 0 4 _aFundus Oculi
650 0 4 _aHumans
650 0 4 _aIntravitreal Injections
650 0 4 _aMacular Edema
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetinal Vein Occlusion
_xdiagnosis
650 0 4 _aRetrospective Studies
650 0 4 _aTomography, Optical Coherence
650 0 4 _aVascular Endothelial Growth Factor A
_xantagonists & inhibitors
650 0 4 _aWet Macular Degeneration
_xdiagnosis
700 1 _aSanabria, MarĂ­a R
773 0 _tOptometry and vision science : official publication of the American Academy of Optometry
_gvol. 95
_gno. 5
_gp. 435-442
856 4 0 _uhttps://doi.org/10.1097/OPX.0000000000001212
_zAvailable from publisher's website
999 _c28315391
_d28315391